[1]
“Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review”, Indian J Pharm Drug Studies, vol. 1, no. 3, pp. 73–78, Dec. 2023, Accessed: Nov. 25, 2024. [Online]. Available: https://mansapublishers.com/index.php/ijpds/article/view/3575